These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 9809109)
1. Clinical and regulatory concerns in Alzheimer's disease management: role of the pharmacist. Feinberg MV; Michocki RJ Am J Health Syst Pharm; 1998 Nov; 55 Suppl 2():S26-31. PubMed ID: 9809109 [TBL] [Abstract][Full Text] [Related]
2. The expert consensus guideline series. Treatment of dementia and its behavioral disturbances. Introduction: methods, commentary, and summary. Alexopoulos GS; Jeste DV; Chung H; Carpenter D; Ross R; Docherty JP Postgrad Med; 2005 Jan; Spec No():6-22. PubMed ID: 17203561 [TBL] [Abstract][Full Text] [Related]
3. The treatment of Alzheimer's disease: the approach from a clinical specialist in the trenches. Hake AM Semin Neurol; 2002 Mar; 22(1):71-4. PubMed ID: 12170395 [TBL] [Abstract][Full Text] [Related]
4. Low-Dose Atypical Antipsychotic Risperidone Improves the 5-Year Outcome in Alzheimer's Disease Patients with Sleep Disturbances. Yin Y; Liu Y; Zhuang J; Pan X; Li P; Yang Y; Li YP; Zhao ZQ; Huang LQ; Zhao ZX Pharmacology; 2015; 96(3-4):155-62. PubMed ID: 26279176 [TBL] [Abstract][Full Text] [Related]
9. [Cholinergic therapy of Alzheimer's disease and its effect on health and quality of life of caregivers to the patients]. Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Suppl 1):33-8. PubMed ID: 20559265 [TBL] [Abstract][Full Text] [Related]
10. Caregiver burden in Alzheimer's disease. Slattum PW; Johnson MA Consult Pharm; 2004 Apr; 19(4):352-62. PubMed ID: 16553479 [TBL] [Abstract][Full Text] [Related]
11. Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options. Lesser JM; Hughes S Geriatrics; 2006 Dec; 61(12):14-20. PubMed ID: 17184138 [TBL] [Abstract][Full Text] [Related]
12. White paper on expanding the role of pharmacists in caring for individuals with Alzheimer's disease: APhA Foundation Coordinating Council to Improve Collaboration in Supporting Patients with Alzheimer's Disease. Skelton JB J Am Pharm Assoc (2003); 2008; 48(6):715-21. PubMed ID: 19019799 [TBL] [Abstract][Full Text] [Related]
13. Knowledge and pharmacological management of Alzheimer's disease by managing community pharmacists: a nationwide study. Zerafa N; Scerri C Int J Clin Pharm; 2016 Dec; 38(6):1416-1424. PubMed ID: 27655307 [TBL] [Abstract][Full Text] [Related]
14. [Pharmaceutical care for patients and their caregivers in Alzheimer's disease and related disorders: a review and new perspectives]. Novais T; Mouchoux C Geriatr Psychol Neuropsychiatr Vieil; 2019 Mar; 17(1):7-19. PubMed ID: 30907370 [TBL] [Abstract][Full Text] [Related]
16. Navigating patients and caregivers through the course of Alzheimer's disease. Aupperle PM J Clin Psychiatry; 2006; 67 Suppl 3():8-14; quiz 23. PubMed ID: 16649846 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological treatment of Alzheimer's dementia: state of the art and current dilemmas. Omerovic M; Hampel H; Teipel SJ; Buerger K World J Biol Psychiatry; 2008; 9(1):69-75. PubMed ID: 17886162 [TBL] [Abstract][Full Text] [Related]
18. Management of behavioral problems in Alzheimer's disease. Gauthier S; Cummings J; Ballard C; Brodaty H; Grossberg G; Robert P; Lyketsos C Int Psychogeriatr; 2010 May; 22(3):346-72. PubMed ID: 20096151 [TBL] [Abstract][Full Text] [Related]
19. The pharmacist's role in managing patients with Alzheimer's disease. Marasco R; Heely JA; Gardner M J Am Pharm Assoc (2003); 2003; 43(5 Suppl 1):S20-1. PubMed ID: 14626518 [TBL] [Abstract][Full Text] [Related]